Naperville, IL -- (SBWIRE) -- 06/06/2012 -- Dainippon Sumitomo Pharma Product Pipeline Review 2012 provides data on the Dainippon Sumitomo Pharma Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Dainippon Sumitomo Pharma Co., Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Dainippon Sumitomo Pharma Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Dainippon Sumitomo Pharma Co., Ltd. - Brief Dainippon Sumitomo Pharma Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Dainippon Sumitomo Pharma Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Dainippon Sumitomo Pharma Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Dainippon Sumitomo Pharma Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Dainippon Sumitomo Pharma Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Dainippon Sumitomo Pharma Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Dainippon Sumitomo Pharma Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Dainippon Sumitomo Pharma Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Dainippon Sumitomo Pharma Co., Ltd. and identify potential opportunities in those areas.
Keyword
Current R&D Portfolio of Dainippon Sumitomo Pharma Co., Ltd.; Dainippon Sumitomo Pharma Co., Ltd. - Key Therapeutics; Dainippon Sumitomo Pharma Co., Ltd. - Pipeline Overview and Promising Molecules; Dainippon Sumitomo Pharma Co., Ltd. - News; Dainippon Sumitomo Pharma Co., Ltd. - Latest Updates; Dainippon Sumitomo Pharma Co., Ltd. - Pipeline; Dainippon Sumitomo Pharma Co., Ltd. - Discontinued/Dormant Projects
To view the detailed table of contents for this report please visit: http://www.reportstack.com/product/67534/dainippon-sumitomo-pharma-co-ltd-product-pipeline-review-2012.html